 |
|
|
| |
Efficacy and Safety of Elebsiran and PEG-IFNα Combination
Therapy vs PEG-IFNα in Participants With Chronic HBV Infection:
Preliminary EOT Results From ENSURE Study
|
| |
| |
AASLD The Liver Meeting, San Diego, CA, November 15-19th, 2024
Jidong Jia1, Bingliang Lin2, Peng Hu3, Qing Xie4, Mark W Douglas5, Fangfang Lv6, Won Young Tak7, Dong
Joon Kim8, Grace Lai-Hung Wong9, Xinyue Chen10, James O'Beirne11, Man Fung Yuen12, Chia-Yen Dai13,
Jeong Heo14, Junqi Niu15, Ke Cao16, Chong Zhu16, Xiaofei Chen16, David Margolis17, Qing Zhu17
|
| |
|
|
|
|
|
